menu
    • menu

    Company profile for RetinalGeniX

    NEW Drugs in Dev: 1
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    RetinalGeniX is an ophthalmic R&D company pioneering High-Resolution Retinal Imaging and Pharmaco-Genetic Mapping™ technologies to prevent blindness through early disease detection and treatment. Our innovative approach not only identifies ocular diseases but also detects early physiological changes linked to systemic conditions such as neurodegenerative, cardiovascular, vascular, metabolic, and diabetic diseases. Committed ...
    RetinalGeniX is an ophthalmic R&D company pioneering High-Resolution Retinal Imaging and Pharmaco-Genetic Mapping™ technologies to prevent blindness through early disease detection and treatment. Our innovative approach not only identifies ocular diseases but also detects early physiological changes linked to systemic conditions such as neurodegenerative, cardiovascular, vascular, metabolic, and diabetic diseases. Committed to advancing precision medicine, RetinalGeniX strives to revolutionize early diagnosis and improve patient outcomes.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    RetinalGeniXUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    409 Apollo Beach Blvd, Ste 6 Apollo Beach, FL 33572-2281
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://retinalgenix.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/retinalgenix-technologies/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    BPI Europe

    BPI Europe

    Not Confirmed

    envelop Contact Supplier

    BPI Europe

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    RetinalGenix Details Science, Mission in AI Retinal Study
    RetinalGenix Details Science, Mission in AI Retinal Study

    14 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/14/3218467/0/en/RetinalGenix-Reports-on-its-Science-and-Mission-in-Light-of-New-AI-Driven-Retinal-Mapping-Study.html

    GLOBENEWSWIRE
    14 Jan 2026
    Share Share
    RetinalgeniX Tech Hires M. Cory Zwerling As CFO, Interim COO
    RetinalgeniX Tech Hires M. Cory Zwerling As CFO, Interim COO

    08 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/09/3202019/0/en/RetinalGenix-Technologies-Agrees-To-Hire-M-Cory-Zwerling-as-CFO-Interim-COO.html

    GLOBENEWSWIRE
    08 Dec 2025
    Share Share
    Retinalgenix Partners Seer Bio For Early Disease Detection
    Retinalgenix Partners Seer Bio For Early Disease Detection

    16 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/16/3167681/0/en/RetinalGenix-Technologies-Contracts-with-Seer-Bio-to-Explore-Early-Detection-of-Neurodegenerative-Systemic-and-Retinal-Diseases.html

    GLOBENEWSWIRE
    16 Oct 2025
    Share Share
    RetinalGeniX & RGEN Lab Partner To Enhance Early Detection
    RetinalGeniX & RGEN Lab Partner To Enhance Early Detection

    01 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/01/3159302/0/en/RetinalGenix-Technologies-and-RGEN-Clinical-Genotyping-Laboratory-Announce-Strategic-Collaboration-to-Advance-Early-Detection-of-Neurodegenerative-Systemic-and-Retinal-Diseases.html

    GLOBENEWSWIRE
    01 Oct 2025
    Share Share
    Retinalgenix Tech Enhances Monitoring Patents For Ocular Care
    Retinalgenix Tech Enhances Monitoring Patents For Ocular Care

    25 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/25/3156103/0/en/RetinalGenix-Technologies-Advances-Home-and-Remote-Monitoring-Patent-Portfolio-Positioning-for-the-Future-of-Ocular-and-Systemic-Disease-Care.html

    GLOBENEWSWIRE
    25 Sep 2025
    Share Share
    RetinalGenix partners LabCorp for DNA/GPS Platform
    RetinalGenix partners LabCorp for DNA/GPS Platform

    27 Jun 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/06/27/3106791/0/en/RetinalGenix-Technologies-Contracts-with-LabCorp-to-Support-DNA-GPS-Platform-for-Advanced-Genetic-and-Retinal-Health-Screening.html

    GLOBENEWSWIRE
    27 Jun 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search